HOME >> BIOLOGY >> NEWS
Brain serotonin enzyme finding might explain psychiatric disorders

DURHAM, N.C. -- Researchers at Duke University Medical Center have provided the first direct evidence in mice for the role of an enzyme that specifically controls the production of serotonin in the brain. Different versions of that serotonin enzyme have a major effect on brain levels of the chemical messenger, which has been linked to many basic behavioral and physiological functions including mood, emotion, sleep and appetite, the researchers reported in the July 9, 2004, issue of Science. The finding has major implications for understanding psychiatric disorders and their treatment, the researchers said.

Serotonin is a "neurotransmitter," a chemical that one neuron uses to trigger a nerve impulse in its neighbors. Thus, serotonin levels can profoundly affect brain function, and therefore behavior.

"For the first time, we've identified a naturally occurring genetic difference that controls the production of serotonin in the brain," said Howard Hughes Medical Institute investigator Marc Caron, Ph.D., James B. Duke professor of cell biology at Duke and senior author of the study.

The finding in mice sets the stage for new insights into the role the serotonin enzyme and the gene that encodes it might play in animal behavior and human psychiatric disorders, said the researchers. Low levels of serotonin have been implicated in many disorders such as depression, anxiety, post-traumatic stress disorder and attention deficit hyperactivity disorder.

The enzyme might also influence patients' responses to the class of drugs known as selective serotonin re-uptake inhibitors or SSRIs, they added. SSRIs include paroxetine (trade name Paxil), sertraline (trade name Zoloft) and fluoxetine (trade name Prozac). The influence of the serotonin enzyme raises the possibility that a genetic test to distinguish which version of the gene a patient has could predict the patient's response to the drugs, Caron said.

The brain is a network of billions of
'"/>

Contact: Kendall Morgan
kendall.morgan@duke.edu
919-660-1306
Duke University Medical Center
8-Jul-2004


Page: 1 2 3

Related biology news :

1. Brain has center for detecting sound motion
2. Brains reward circuitry revealed in procrastinating primates
3. Brain development and puberty may be key factors in learning disorders
4. Organization for Human Brain Mapping 2004 Annual Meeting
5. Brain disease research, particle physics meet in the middle (ware)
6. Brain control
7. Brain cells become more discriminating when they work together
8. Brain signal predicts working memory prowess
9. Brain areas identified that decode emotions of others
10. Brain Centre gives Wales a world lead
11. AAAS hosts Battle of the Brains to choose area student for international competition

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2019)... ... July 30, 2019 , ... Keck Graduate Institute (KGI) ... Rathmann Professor in Bioprocessing and Director of the Amgen Bioprocessing Center, effective July ... industry and possesses more than 25 years of global experience in bioprocessing,” Schuster ...
(Date:7/26/2019)... LOS ANGELES (PRWEB) , ... July 26, 2019 ... ... pleased to announce an exclusive interview with Helius Medical Technologies CEO Phil Deschamps ... or trauma. , Helius Medical Technologies is a neurotech company in ...
(Date:7/23/2019)... ... 22, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem ... of a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical ... in the knee. , This is the first of several planned clinical ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative ... Inc. (PSC) , has announced that their GMP facility for cell production is ... for manufacturing. This is an important milestone for VetStem as it expands ...
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ... device industries, announced today that they will be receiving 3 awards at the 2019 ... WCCT received 2 awards in the categories of overall Quality and Compatibility (Access to ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... applications from the USPTO providing proprietary interest to our methodology, processes, and ... DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our proprietary sleep ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object Pharma, Inc., ... strategic acquisition of Metabiologics, Inc., a globally recognized leader in the production and ... commercialization rights to a full spectrum of botulinum neurotoxins, as well as a ...
Breaking Biology Technology:
Cached News: